B-859-35, a new drug with anti-tumor activity reverses multi-drug resistance
- 1 April 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 47 (6) , 870-874
- https://doi.org/10.1002/ijc.2910470614
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Expression of mdr1 and mdr3 Multidrug-resistance Genes in Human Acute and Chronic Leukemias and Association With Stimulation of Drug Accumulation by CyclosporineJNCI Journal of the National Cancer Institute, 1990
- Multiple Patterns of Resistance of Human Leukemia Cell Sublines to Amsacrine AnaloguesJNCI Journal of the National Cancer Institute, 1990
- (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of α1-adrenoceptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- Multidrug Resistance During Chemical Carcinogenesis: A Mechanism Revealed?JNCI Journal of the National Cancer Institute, 1988
- Enhancement of the antiproliferative effect of cis‐diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase CInternational Journal of Cancer, 1988
- Isolation and genetic characterization of human KB cell lines resistant to multiple drugsSomatic Cell and Molecular Genetics, 1985
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984
- Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed.Molecular and Cellular Biology, 1983
- Generalized Equations for the Analysis of Inhibitions of Michaelis-Menten and Higher-Order Kinetic Systems with Two or More Mutually Exclusive and Nonexclusive InhibitorsEuropean Journal of Biochemistry, 1981